Fraunhofer researchers developing new system for rapid analysis of urinary stones

Kidney stones rank among the most common illnesses. Their recurrence might be prevented with the right postoperative care. However, for this to be effective, composition of the stones should be known. Fraunhofer researchers are developing a system for rapid analysis of urinary stones immediately after the surgical procedure.

An increasing number of citizens in western European countries (including Germany) are affected by kidney stone disease. The number of new cases has tripled in the last 10 years. Kidney stones are often no larger than a grain of rice, yet some can grow to a diameter of several centimeters. Sometimes a urinary stone might block  the ureter, causing colick pain in the flank. If it cannot be dissolved, the kidney stone is treated using extracorporeal shock-wave therapy or applying minimally invasive endoscopic modalities.

Many patients suffer from disease recurrence and need retreatments. Scientific studies have shown that new stone formation might be reduced by 50 percent if individualized follow-up care and proper metaphylaxis measures are offered to the patient. The recommendations regarding dietary habits or the use of particular medication strategies are based on the knowledge of the stone composition. In collaboration with an industrial partner and the Division of Urotechnology, University Medical Center Freiburg, researchers at the Fraunhofer Institute for Physical Measurement Techniques IPM are developing a novel Raman spectroscopy based diagnostic system for rapid and automated analysis of kidney stones, thus significantly improving patient follow-up care after stone treatment. Fraunhofer researchers in this project are working hand in hand with urologists specialized in modern methods of treating urinary stone disease.

"Only a small number of kidney stone patients receive a comprehensive consultation and follow-up after they have been treated," says physician and researcher Dr. Arkadiusz Miernik at Fraunhofer IPM. This may be because conventional stone analysis technologies such as infrared spectroscopy are costly and time-consuming, including preperation of stone samples. Analysis can also only be performed in a dedicated laboratory facility. Since only a few centers offer this type of analysis, it can take up to three weeks to receive results. "The patient in most cases has already been discharged and will not be seeing the doctor again. We advise stone patients to drink plenty of fluids, increase physical activities and lose weight if necessary. Unfortunately this is only a general recommendation. From the clinical point of view we need individualized approaches and these must include results of a compositional analysis of the stone. This allows us to evaluate the individual risk of disease recurrence and detect potential metabolic abnormalities," says Miernik.

Preparation of stone samples no longer necessary

Miernik and his team use a technique known as Raman spectroscopy, which allows them to rapidly characterize and conclusively identify specific stone types. This method utilizes a characteristic spectrum in the visible wavelength range of the examined sample called a "chemical fingerprint". "These samples are illuminated using laser light. About 1 percent of the photons are reflected back in a different wave spectrum highly specific to the sample. We record these signals in a database," explains Miernik. Researchers use computer software to filter out the fluorescent background occuring during Raman spectroscopy using computer software.

This method employs relatively inexpensive optical components, and it also works on wet, unprepared samples. The time taken to prepare specimens is substantially reduced. "The stones previously had to be dried and pulverized prior to analysis. Our system makes this unnecessary. Stone fragments collected during the surgical procedure do not need to be further processed. They can in principle be put directly into the Raman spectrometer for analysis," explains Miernik. Currently there are a few specialized laboratories that can carry out this procedure using large-scale analytical equipment. A compact device suitable for use in a clinical setting and allowing immediate, post interventional automated analysis is not yet available.

A demonstration system, including the hardware and software required for stone analysis developed by the Fraunhofer IPM researchers, already exists as a prototype. This prototype must first be made more compact before it is ready for the market. A unique feature of the system is its spectral database. An information index has been built up of data on the nine pure substances making up 99 percent of urinary stones. The researchers examined nearly 160 kidney stone samples in setting up the software during the first validation phase. Moreover, the results were confirmed after a conventional infrared based analysis in a reference laboratory. "Once the complete system is ready for clinical use, the physician (urologist) will be able to examine stone samples directly after surgical intervention on his own, thus increasing the quality of patients' care substantially." says Miernik.

Source: https://www.fraunhofer.de/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
NIH grants $2.6 million to explore the effects of high blood-pressure drugs in CKD patients